Recent advances in the development of small-molecule drugs based on covalent reversible inhibitors
{{output}}
Reversible covalent inhibitors (RCIs) are a class of small-molecule drugs that engage target proteins through covalent bonds. Unlike irreversible covalent inhibitors, RCIs can dissociate from their target. This reversibility, combined with high selectivity, ar... ...
